Baiteng Zhao
赵柏腾
elsewhere's corpus does not cover this subject. The retrieved material contains no document chunks actually about Baiteng Zhao — only background articles in which the name may appear incidentally, none of which can be used to state facts about who they are.
AI-generated — may contain errors, please verify.
Baiteng ZhaoPerson
赵柏腾
No graph yet
Mentioned in 5 articles
Coverage
Genmab Acquires ProfoundBio for $1.8 Billion | Gaorong Ventures News
Accelerate the development and unlock the full potential of ADC therapies.
高榕创投·ProfoundBio Closes $112 Million Series B to Advance ADC Drug Candidates Into Pivotal Clinical Development
Delivering breakthrough therapies for cancer patients.
高榕创投·ProfoundBio Closes $70 Million Series A+ Round to Advance Novel Antibody-Drug Conjugate Clinical Development
Accelerate preclinical development across multiple pipelines while further deepening and expanding the ADC innovative technology platform.
高榕创投·Platonic Bio Closes Oversubscribed $55 Million Series A to Accelerate ADC Drug and Immuno-Oncology Platform Development
Enabling best-in-class and first-in-class ADCs to advance into clinical development.
高榕创投·
